Air quality and cancer

Outdoor and indoor air pollution are now recognized as causes of cancer, most strongly lung cancer. The International Agency for Research on Cancer classifies outdoor air pollution and particulate matter as Group 1 carcinogens. Beyond lung cancer, air pollution is being studied for its contribution to breast, gastrointestinal, esophageal, and other cancers, as well as for its role in worsening outcomes after a cancer diagnosis.

The most-studied component of air pollution is fine particulate matter (PM2.5, particles smaller than 2.5 micrometers in aerodynamic diameter), which is small enough to cross the alveolar wall and enter the bloodstream. PM2.5 carries adsorbed polycyclic aromatic hydrocarbons (PAHs), heavy metals, and other reactive species that drive oxidative stress, mitochondrial dysfunction, and DNA strand breaks in lung epithelium. Inflammation from chronic exposure produces cytokine release and recruitment of macrophages, which can support tumor initiation and progression. Inhaled iron-containing particles have been shown to drive lung carcinogenesis through specific transcriptomic signaling axes. Indoor air pollution from solid-fuel combustion, cooking-oil fumes, and waterpipe smoke generates similar carcinogens, often at concentrations exceeding outdoor exposure in affected populations. Co-exposures (smoking, radon, asbestos) interact with particulate matter to increase risk further.

A UK Biobank prospective cohort of lung cancer survivors found that higher long-term particulate matter exposure was associated with increased risk of a second primary lung cancer, including in never-smokers. A Taiwan Biobank case-control study of fine particulate matter and breast cancer found independent and combined effects with the genetic variants ESR1 rs2046210 and FGFR2 rs2981582, suggesting gene-environment interaction. A retrospective cohort from Liaoning, China examined pre-diagnosis and post-treatment exposures to particulate matter of different size fractions and reported associations with poorer breast cancer-specific survival. A systematic review and meta-analysis of air pollution and gastrointestinal disease found significant associations between long-term PM2.5 and PM10 exposure and several gastrointestinal diseases, including digestive cancers. A Chinese population-based case-control study identified indoor air pollution from cooking and heating as a contributor to esophageal cancer risk, an exposure with a heavy burden in lower-income populations using solid fuels. Two case-control analyses suggested that industrial point source emissions, used as proxies for ambient industrial exposure, were associated with breast and lung cancer incidence in nearby populations. A spatial epidemiologic analysis across European NUTS-2 regions found that lung cancer mortality clustered in areas with combined environmental and tobacco exposures. A Japanese study of waterpipe-serving venues measured indoor air pollution and documented carbon monoxide and particulate exposures relevant to long-term cancer risk.

People living near major roads, industrial point sources, or in high-pollution urban centers experience the largest cumulative dose. Occupational exposures concentrate the risk further: a Chinese study of urban sanitation workers found a high prevalence of high-risk lung nodules, especially in those with worse physical health-related quality of life. Never-smokers may be especially affected because their cancer risk lacks a dominant confounder, making the air pollution signal easier to detect. Genetic susceptibility variants in estrogen receptor and fibroblast growth factor receptor genes amplify the breast cancer signal in women exposed to particulate matter. Lower-income populations and those in informal occupations bear disproportionate exposure to both indoor and outdoor pollution, often layered on top of occupational dusts and fumes.

Outdoor air pollution and particulate matter are classified as Group 1 carcinogens by the International Agency for Research on Cancer, which represents the strongest tier of evidence for cancer causation. Evidence is most consistent for lung cancer and growing for breast and gastrointestinal cancers. Most data come from large cohort and case-control studies, with confounding from smoking, occupation, and socioeconomic status carefully addressed in newer designs. Randomized intervention trials are not feasible at population scale, but natural experiments around emission reductions show measurable health gains. Newer data-science methods are integrating residential history with pollution monitoring to refine individual exposure estimates.

Research consistently links higher long-term exposure to fine particulate matter and certain industrial pollutants with elevated cancer risk and poorer survival, especially for lung cancer. The signal extends to never-smokers and to cancer types beyond the lung, with stronger effects in occupationally exposed and genetically susceptible groups. Reducing personal exposure where feasible, alongside policy-level air-quality improvements, is the direction the evidence points.